Clinical Trial Update: A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors [Phase 1, Phase 2]

View source ↗

Summary

Cantargia AB's CAN04 first-in-human study in solid malignant tumors (Phase 1/2) has completed. The trial encompassed several indications, including non-small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Non-small Cell Lung Cancer
• Pancreatic Ductal Adenocarcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• CAN04

Snippet

Sponsor: Cantargia AB | Conditions: Non Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED